What We Are Trying to Accomplish
To invest in MS research by funding the National Institutes of Health (NIH) and Multiple Sclerosis Congressionally Directed Medical Research Program (CDMRP).
The NIH is the country’s premier institution for health research and the single largest source of funding for MS research projects in the world. The MS CDMRP funds high risk, high reward MS research that is complementary to that conducted by the NIH.
Happening at the National Level
In the FY 2016 budget, the NIH received a $2 billion increase--for a total of $32.1 billion. Congress has started work on the 2017 budget. The Senate Appropriations Committee has recommended $34.1 billion and the House Appropriations Committee has recommended $33.3 billion.
The MS CDMRP received a $1 million increase in FY 2016--for a total of $6 million. For 2017, the House Appropriations Committee recommended $6 million for the MS CDMRP. The Senate Appropriations Committee does not provide specific funding for the MS CDMRP, but has recommended a five percent increase over its 2016 funding level for medical research.
Congress did not complete its 2017 spending bill by the start of the Fiscal Year October 1, so to avoid a government shut-down, Congress passed a continuing resolution or “CR” that temporarily funds the government agencies and programs. This “CR” expires on December 9 and the government will shut down if Congress does not pass another CR or complete its work on the 2017 federal budget.
Did your U.S. Senators support the MS CDMRP? Click here to check their voting record!